What’s new and on the horizon for patients with CLL?
An interview with Prof Stephan Stilgenbauer (duration 11:30)
In this podcast, Professor Stilgenbauer will evaluate how ongoing research into CLL disease biology may impact clinical management in the future and the potential of novel treatment approaches.
After listening to this podcast you should be able to:
- Review ongoing research into CLL disease biology and the novel treatment options being developed for patients with this disease
- Stephan Stilgenbauer (Germany)